A few weeks ago, the Centers for Disease Control reported that “the number of cancer survivors in the
AD
is the sixth leading cause of death in this country, and the only one of the top ten causes of death
with no means of prevention or cure. AD is also the fastest growing cause of
death in this country. More than 5
million Americans have already been diagnosed with AD, and with so many baby
boomers turning 65 each day this number is expected to triple over the next
30-40 years.
Our
country faces a huge health crisis with AD that will greatly increase costs to
taxpayers in the years ahead. According
to Maine Senator Susan Collins, “We spend one penny on research for every
dollar the federal government spends on care for patients with
Alzheimer’s. That just doesn’t make any
sense.” Dr. Stanley Prusiner, director
of the Institute for Neurodegenerative Diseases at UC, San Francisco , recently stated that
“Alzheimer’s is a cancer sized problem requiring
a cancer sized solution. Yet, to date
the Alzheimer’s field is grossly underfunded, at a level of less than 10% that
of cancer.” This year, NIH will fund more than $6 billion on
cancer research … but less than $500 million for AD research. NIH
will also spend $3 billion on HIV-AIDS research this year, more
than six times the money that will be
spent on Alzheimer’s research. Yet, according
to a recent issue of Time Magazine, “The numbers of people living
with HIV have leveled off while the rates of deaths and new infections have
fallen.” The number of deaths
attributable to HIV declined 29% between
2000-2008. But according to the
Alzheimer’s Association’s recent report, “2011 Alzheimer’s Disease Facts and
Figures,” during this same time period the number of deaths attributable to AD rose 66%,
Long
term care for Alzheimer’s patients already costs this country nearly $200
billion a year. According to Senator
Collins, “If nothing is done to slow or stop the disease, Alzheimer’s will cost
the United States
$20 trillion over the next 40 years. The
average annual Medicare payment for an individual with Alzheimer’s is three
times higher than for those without the condition.” And according to Dr. Prunsiner, for Medicaid
patients, “the costs of an Alzheimer’s beneficiary are nine times that of a
non-Alzheimer’s beneficiary.”
My
wife has AD. Symptoms started appearing
at age 59 and she was officially diagnosed at age 63. No treatment or cure will arrive in time for
her. But if our country begins to devote
more funding for AD research as we have for cancer … or even as we have for
HIV/AIDS … then perhaps one day people will be able to say that they have lived
with this diagnosis for 25 years … and are AD survivors.
Published in Journal of the American Geriatrics Society, December, 2011, Vol. 59, No. 12, pp. 2396-97. Access at: http://onlinelibrary.wiley.com/doi.10.1111/j.1532-5415.2011.03694.x/full
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.